ABCC3 and hepatocellular carcinoma: Increased expression of the ATP binding cassette subfamily C member 3 (ABCC3) transporter has been reported after administrating the first-line chemotherapy [18]; moreover, this transporter has been proposed as a marker of HCC progression and drug resistance [19].